News

A recent WHO overview said that access to affordable treatment, including insulin, is essential for survival, but it never ...
Novo Nordisk launches weightloss drug Wegovy in India at competitive prices, facing patent battles and high demand.
Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...
DENVER — Hiding deep inside the body, a dangerous type of fat wraps itself around vital organs such as the kidneys, liver and ...
Ten people have been effectively cured of their type 1 diabetes after a breakthrough infusion of a new treatment on the path ...
Understanding the root causes and appropriate interventions is essential for effective and culturally sensitive hair growth management.
Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...
J.J. Spaun knows as well as anyone how one little shot can make such a huge difference, even if it's only 85 yards to a green ...
A small study found that a stem cell-derived treatment helped people with Type 1 diabetes produce their own insulin and, in most cases, enabled patients to discontinue use of external insulin ...
Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...
A woman with Type 1 diabetes said her diagnosis felt like a "death sentence" — but with a new stem cell therapy, she's now ...
The group pointed to an initiative of Juha Sipilä's (Cen) government to increase users' co-payments for all diabetes ...